<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03441438</url>
  </required_header>
  <id_info>
    <org_study_id>20382</org_study_id>
    <nct_id>NCT03441438</nct_id>
  </id_info>
  <brief_title>Mechanisms of Alcohol Sensitivity in AERD</brief_title>
  <official_title>Mechanisms of Alcohol Sensitivity in Aspirin Exacerbated Respiratory Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine what type of reactions in the body may be
      responsible for the respiratory symptoms that occur when patients with Aspirin Exacerbated
      Respiratory Disease (AERD) drink alcoholic beverages. These reactions are most often seen
      with red wine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective trial of approximately 60 subjects with AERD to explore the mechanisms
      behind the physiologic reactions that occur when drinking alcoholic beverages. At various
      time points patients will be asked to ingest a variety of substances found in red wine after
      which blood and urine markers of the reaction will be measured.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24 Hour Urinary Leukotriene-E4 (LTE4)</measure>
    <time_frame>24 hour</time_frame>
    <description>Urine LTE4 ng/mg Cr</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>24 Hour Urinary Prostaglandin-D2 (PGD2) metabolite</measure>
    <time_frame>24 hour collection</time_frame>
    <description>Urine PGD2 metabolite ng/mg Cr</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Whole blood Activated Basophil Level</measure>
    <time_frame>2 hours after ingestion</time_frame>
    <description>Proportion of activated basophils in whole blood after ingestion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Whole Blood Activated Eosinophil Level</measure>
    <time_frame>2 hours after ingestion</time_frame>
    <description>Proportion of activated eosinophils in whole blood after ingestion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Whole Blood tryptase</measure>
    <time_frame>2 hours after ingestion</time_frame>
    <description>Level of tryptase concentration in whole blood</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Aspirin-Sensitive Asthma With Nasal Polyps</condition>
  <condition>Samter's Syndrome</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients without asthma or aspirin intolerance who may or may not react to alcoholic beverages</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin Tolerant Asthma</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with asthma who are tolerant to aspirin and/or other NSAIDs and note sensitivity to alcoholic beverages</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin Intolerant Asthma / AERD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with AERD who note sensitivity to alcoholic beverages</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Water</intervention_name>
    <description>Serum and urine markers will be obtained after drinking 5 oz of water</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Aspirin Tolerant Asthma</arm_group_label>
    <arm_group_label>Aspirin Intolerant Asthma / AERD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Red wine</intervention_name>
    <description>Serum and urine markers will be obtained after drinking 5 oz of water</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Aspirin Tolerant Asthma</arm_group_label>
    <arm_group_label>Aspirin Intolerant Asthma / AERD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Polyphenolic Compounds</intervention_name>
    <description>Serum and urine markers will be obtained after consuming 100 mg of provinols powder</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Aspirin Tolerant Asthma</arm_group_label>
    <arm_group_label>Aspirin Intolerant Asthma / AERD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Controls - must be 21 years or older

          -  Aspirin Tolerant Asthma and AERD arms must note a sensitivity to alcoholic beverages

        Exclusion Criteria:

          -  Enzymopathies

          -  Mastocytosis

          -  Alcoholism

          -  Prior severe respiratory reaction to alcohol consumption

          -  Current pregnancy

          -  Monoamine Oxidase Inhibitor (MAOI) use

          -  Age under 21

          -  Use of leukotriene modifier 1 week before study intervention

          -  Having undergone and maintained aspirin desensitization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Spencer C Payne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BJ Ferrebee-Ghamandi, MHA</last_name>
    <phone>434-243-1558</phone>
    <email>Bjf8j@hscmail.mcc.virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BJ Ferrebee-Ghamandi, MHA</last_name>
      <phone>434-243-1558</phone>
      <email>Bjf8j@hscmail.mcc.virginia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cardet JC, White AA, Barrett NA, Feldweg AM, Wickner PG, Savage J, Bhattacharyya N, Laidlaw TM. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):208-13.. doi: 10.1016/j.jaip.2013.12.003.</citation>
    <PMID>24607050</PMID>
  </reference>
  <reference>
    <citation>Payne SC. Re: Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):644. doi: 10.1016/j.jaip.2014.05.003.</citation>
    <PMID>25213072</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2018</study_first_submitted>
  <study_first_submitted_qc>February 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2018</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alcohol sensitivity</keyword>
  <keyword>red wine</keyword>
  <keyword>aerd</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

